SOLITRAL CAPSULE is a combination of Alfuzosin and Solifenacin which belongs to the group of medicines called Alpha blockers and Urinary antispasmodics respectively. It is used to manage overactive bladder (sudden uncontrollable urge to urinate) and other lower urinary tract symptoms (such as incomplete voiding, painful urination, slow or scanty urine or frequent urination at night) associated with Benign Prostatic Hyperplasia (BPH) or other bladder problems.
Benign Prostatic Hyperplasia (also known enlarged prostate) is a non-cancerous growth of prostate gland caused due to increased production of a stress hormone called dihydrotestosterone (DHT) in aging men.
Prior to the management, your doctor will access your urinary tract for any signs of urinary tract infections. Before taking SOLITRAL CAPSULE inform your doctor if you have any kidney or heart disease or due to have any upcoming surgery.
SOLITRAL CAPSULE is not suitable for use in children and adolescents (aged below 18 years). It should be used with caution among elderly patients (65 years or above) due to increased risk of side effects or low blood pressure.
The most common side effects of SOLITRAL CAPSULE are feeling dizzy or faint, headache, tiredness or weakness, dry mouth, constipation and stomach discomfort. Consult your doctor if any of the symptoms worsen.
No content available
